by QFR Solutions | Mar 13, 2020 | News
Source: PRWeb Neauvia North America has announced that the U.S. Food and Drug Administration (FDA) has given Class II clearance to Plasma IQ, an innovative, non-surgical solution that helps improve the appearance of aging skin in delicate areas of the face. The device...
by QFR Solutions | Jan 27, 2020 | News
Source: Fierce Biotech A report out this week by PwC thinks biotech could be in for a good year for deals as it sees the momentum from 2019 growing, although don’t expect many mega-deals. In the final year of the decade, a new report out called “Global Pharma...
by angelliu | Jan 7, 2020 | News
Source: FierceBiotech Dermatology player Arcutis Biotherapeutics set up shop in 2016 but stayed under the radar until early last year. Now, with a trio of clinical-stage programs and more than $160 million in the bank, the company is looking to hit the street with a...
by QFR Solutions | Nov 25, 2019 | News
Source: BioSpace Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug candidates, today announced it ranked number...
by QFR Solutions | Nov 5, 2019 | News
Source: FierceBiotech Stryker is moving to acquire fellow devicemaker Wright Medical in a $4 billion play to gain a stronger foothold in fast-growing orthopedic segments. The Amsterdam and Memphis, Tennessee-based Wright Medical posted $836 million in global net sales...
by QFR Solutions | Oct 10, 2019 | News
Source: FierceBiotech UCB Pharma has struck a $2.5 billion (€2.2 billion) deal to acquire Ra Pharmaceuticals. The takeover will give UCB control of a phase 3 rival to Alexion’s Soliris that some analysts have tipped to rack up blockbuster sales. Ra is focused on a...
